Zalutumumab in Head and Neck Cancer

Clinical trial NCT00093041 · COMPLETED

Trial details

NCT number: NCT00093041
Sponsor: Genmab
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Head and Neck Neoplasms

Start date: 2003-12-01
Primary completion: 2005-01-12
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.